Cat. No. |
Product Name / Activity |
5318 |
AEE 788 |
| Potent EGFR and VEGFR inhibitor |
6812 |
Afatinib dimaleate |
| Potent dual specificity EGFR/HER2 inhibitor; active in vivo |
1276 |
AG 1478 hydrochloride |
| Highly potent EGFR-kinase inhibitor |
0414 |
AG 490 |
| EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor |
1555 |
AG 825 |
| Selective ErbB2 inhibitor |
5916 |
Canertinib dihydrochloride |
| Potent EGFR kinase inhibitor |
6231 |
Dacomitinib |
| Potent irreversible pan ErbB inhibitor |
7424 |
EMI 48 |
| Inhibitor of EGFR mutants |
7194 |
Erlotinib Hydrochloride |
| Potent, reversible EGFR tyrosine kinase inhibitor |
1110 |
Genistein |
| EGFR kinase inhibitor. Also estrogen and PPARγ ligand |
2239 |
GW 583340 dihydrochloride |
| Potent dual EGFR/ErbB2 inhibitor; orally active |
6813 |
Ibrutinib |
| Potent ErbB4 inhibitor; also inhibits BTK |
3000 |
Iressa |
| Orally active, selective EGFR inhibitor |
6962 |
JBJ-03-142-02 |
| Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors |
3352 |
JNJ 28871063 hydrochloride |
| Potent ErbB receptor family inhibitor |
6811 |
Lapatinib |
| Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor |
7371 |
Neratinib |
| Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor |
2615 |
PD 158780 |
| Potent ErbB receptor family inhibitor |
6349 |
Pelitinib |
| Potent and irreversible EGFR inhibitor; orally bioavailable |
4941 |
PKI 166 hydrochloride |
| Potent EGFR-kinase inhibitor |
2794 |
PP 3 |
| EGFR-kinase inhibitor. Also Src kinase negative control |
3599 |
TAK 165 |
| Potent and selective ErbB2 inhibitor |
7640 |
Tucatinib |
| Potent and selective ErbB2 inhibitor |
6290 |
WZ 4002 |
| Potent mutant-selective EGFR inhibitor |